Acute exposure to Helicobacter pylori causes cell damage and impairs the processes of cell migration and proliferation in cultured gastric mucosal cells in vitro. EGF-related growth factors play a major role in protecting gastric mucosa against injury, and are involved in the process of gastric mucosal healing. We therefore studied the acute effect of H. pylori on expression of EGF-related growth factors and the proliferative response to these factors in gastric mucosal cells (MKN 28) derived from gastric adenocarcinoma. 
Introduction
Helicobacter pylori is the major causative agent of chronic superficial gastritis, and plays a central role in the etiology of peptic ulcer disease in humans (1, 2). Moreover, epidemiological studies suggest that infection with H. pylori increases the risk for developing adenocarcinoma of the distal stomach (3, 4) . The mechanisms whereby H. pylori causes disease are not completely elucidated. In addition to virulence factors common to all clinical isolates (5, 6) , two factors have been described that are produced by ‫ف‬ 60% of wild-type isolates of H. pylori: ( a ) an ‫ف‬ 90-kD cytotoxin (VacA) that causes vacuole formation in epithelial cells (7) (8) (9) , and ( b ) a 120-140-kD immunodominant protein (CagA; references 10 and 11). Essentially, all H. pylori strains possess vacA, but those that have the cytotoxin phenotype are referred to as Tox ϩ . In contrast, only ‫ف‬ 60% of wild-type H. pylori strains possess cagA ; all of these are CagA ϩ . An increasing body of evidence indicates that, in western countries, H. pylori strains producing both CagA and cytotoxic VacA are preferentially associated with development of peptic ulcer disease and gastric cancer (9, 12, 13) . We have recently shown that H. pylori broth culture filtrates, besides causing vacuolating damage (14) , also alter the processes of cell migration and proliferation in gastric mucosal cells in vitro (15) .
EGF-related peptides are polypeptides that share structural homology and a similar spectrum of biological activities exerted through interaction with a common cell surface receptor (EGFr; reference 16).
1 EGF-related growth factors prevent drug-induced damage to the rat gastric mucosa (17, 18) and stimulate epithelial cell migration and proliferation (19) (20) (21) , the main processes involved in healing gastroduodenal ulceration (22) . Moreover, increased expression of EGF-related peptides and of EGFr follows gastric mucosal injury (23) (24) (25) , thus supporting the concept that these peptides acting through the EGFr participate in recovery of gastric mucosal integrity after injury (26, 27) . Whether H. pylori infection alters expression of EGF-related growth factors, and whether these peptides play any role in the host response to H. pylori infection have not been studied.
This study was therefore designed to determine whether H. pylori alters expression of any of the EGF receptor (EGFr) ligands and, if so, whether specific bacterial virulence factors were responsible for this effect. Herein, we demonstrate that H. pylori induces expression of amphiregulin (AR) and heparin-binding EGF-like growth factor (HB-EGF), but not TGF ␣ , in MKN 28 gastric mucosal cells, effects that are independent of several known bacterial virulence factors. In addition, we demonstrate that pretreatment of cells with H. pylori broth culture filtrate blocks the mitogenic effect of exogenous AR or HB-EGF by a mechanism independent of EGFr downregulation or inactivation.
Methods
Cell culture. MKN 28 cells are derived from a human gastric tubular adenocarcinoma (28) , and show gastric-type differentiation (29, 30) . Cells were grown in DMEM supplemented with 10% FCS and 1% antibiotic-antimycotic solution (Gibco Laboratories, Grand Island, NY) at 37 Њ C in a humidified atmosphere of 5% CO 2 in air. Cells were grown in 100-mm dishes for RNA extraction, and in 24-well dishes for proliferation and binding studies.
Bacterial strains and growth conditions. We have used the urease-positive Tox ϩ CagA ϩ wild-type H. pylori 60190 strain (ATCC 49503) and isogenic mutants in which vacA, cagA, vacA, and cagA, picA, or picB genes were disrupted by insertional mutagenesis (8, (31) (32) (33) . We also used the Tox
Ϫ

CagA
Ϫ H. pylori strain Bx2 U ϩ and its urease-negative mutant Bx2 U Ϫ (provided by F. Megraud, Bordeaux, France) and the CCUG 17874 (Tox ϩ CagA ϩ ) strain (from the culture collection of the University of Goteborg, Goteborg, Sweden). Bacteria were grown in brucella broth supplemented with 5% FCS (Gibco Laboratories) for 24-36 h at 37 Њ C in a thermostatic shaker under microaerobic conditions. As previously described (14) , when the bacterial suspensions reached 1.2 OD U at 450 nm, bacteria were removed by centrifugation, and the supernatants were sterilized by passage through a 0.22-m pore-size cellulose acetate filter (Nalgene Co., Rochester, NY) to obtain the broth culture filtrates. Broth culture filtrates from different bacterial strains and different preparations from the same strain were standardized by growing the bacterial suspensions until they reached an OD of 1.2 U at 450 nm, which corresponds to a bacterial concentration of 5 ϫ 10 8 CFU/ml. In the experiments with dialyzed broth culture filtrates, aliquots of both H. pylori broth culture filtrates and control filtrates were dialyzed against HBSS for 36 h in dialysis tubing with a 12-kD cutoff (Sigma Chemical Co., Milano, Italy). The presence or absence of VacA and/or CagA in H. pylori cells or filtrate was verified by means of SDS-PAGE followed by immunoblotting with anti-VacA or anti-CagA polyclonal antisera (7, 34) . In the experiments with bacterial suspensions, cells were incubated with bacterial preparations at a concentration of 5 ϫ 10 7 CFU/ ml in DMEM supplemented with 10% FCS.
RNA isolation and Northern analysis. Total RNA was isolated from MKN 28 cells by the guanidinium thiocyanate acid-phenol procedure (35) and subjected to Northern analysis as described previously (36) . In brief, 10 g of total RNA per lane was separated by electrophoresis in 1% agarose-formaldehyde gels. RNA was transferred to Hybond-N ϩ (Amersham Corp., Milano, Italy), cross-linked (UV Stratalinker-1800; Stratagene, La Jolla, CA), and hybridized to 32 P-labeled cDNA probes. 32 P-labeled isotopes were from Amersham Corp. The TGF ␣ probe was a 1.27-kb Eco RI cDNA (37), the HB-EGF probe was a 1.102-kb Eco RI cDNA (38) , the AR probe was a 0.87-kb Eco RI-HinD III cDNA of (39) , and the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe was a 1.5-kb Bam HI cDNA (40) . TGF ␣ , HB-EGF, and AR mRNA levels were normalized to mRNA levels of the constitutively expressed GAPDH gene. mRNA levels were quantitated by densitometric scanning of the autoradiograph using a Howtek Scanmaster-3 densitometer with RFL Print-TM software (Pharmacia Biotech, Cologno Monzese, Italy).
Collection of conditioned medium. Cells were grown to semiconfluency in serum-containing medium. Semiconfluent monolayers were then washed twice with PBS and incubated for 24 h with broth culture filtrate from the H. pylori 60190 (wild-type) strain or with control (uninoculated) filtrate diluted 1:3 in serum-free medium. At the end of the incubation period, conditioned medium was harvested, centrifuged (4,000 g for 20 min at 4 Њ C) and concentrated using Centricon 3 microconcentrators (Amicon, Inc., Beverly, MA).
Preparation of cell extracts and immunoprecipitation. At the end of the incubation period, cells were washed twice with ice-cold PBS and incubated for 20 min at 4 Њ C in lysis buffer containing 25 mM TrisHCl (pH 8.0), 150 mM NaCl, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM PMSF (Sigma Chemical Co., Milano, Italy), 1% (vol/vol) Triton X-100, and 0.3 g/ml aprotinin (Sigma Chemical Co.). Cells were dislodged with a cell scraper. The lysates were cleared by microfuging at 14,000 rpm for 20 min at 4 Њ C. Immunoprecipitation was as described by Auricchio et al. (41) . In brief, 1 ml of lysate was diluted with lysis buffer to a final concentration of 1 mg/ml and incubated for 1 h with 5 g of rabbit anti-mouse IgG (Sigma Chemical Co.) and 40 l of protein G-Sepharose (50% suspension; Pharmacia Biotech Inc., Cologno Monzese, Italy). The samples were centrifuged, and supernatants were incubated overnight with 3 g/ml of anti-EGFr mouse monoclonal antibody, clone LA22 (Upstate Biotechnology Inc., Lake Placid, NY). Each sample was added to 100 l of protein G-Sepharose (50% suspension), and was incubated for an additional hour. The samples were centrifuged, the pellets were washed with lysis buffer, and the proteins were eluted by boiling in Laemmli sample buffer.
Western blot analysis. After electrophoresis, proteins were blotted by electrotransfer to BA 85 0.45-m protan nitrocellulose filters (Schleicher & Schuell, Inc., Dassel, Germany). After blocking with 10% BSA in TTBS (10 mM Tris, pH 7.5, 150 mM NaCl, 0.05% Tween 20), filters were probed with specific antibodies, and protein was visualized with peroxidase-coupled secondary antibody using the enhanced chemiluminescence detection system (ECL; Amersham Corp, Milano, Italy). The antibodies used in our studies were as follows: 2998 rabbit polyclonal anti-human HB-EGF antibody (42) Binding assays. Cells were seeded onto 24-well dishes at the concentration of 5 ϫ 10 4 cells/well. When monolayers were 50% confluent, cells received serum-free medium for 24 h. Subsequently, cells were incubated with serum-free medium, uninoculated broth filtrate, or broth culture filtrate from H. pylori 60190 strain for 24 h. Before the beginning of each assay, the cells were washed three times with 4 Њ C chilled binding medium that consisted of Krebs-Ringer/ (2-hydroxy-ethyl)-1-piperazineethanesulfonic acid containing 0.5% BSA and adjusted to pH 7.4. 400-l aliquots of the binding medium containing 0.06 nmol/liter [ ]EGF. The cultures were then solubilized by adding 1.0 ml of 1 N NaOH to each well. After 30 min, the contents of each well were withdrawn and added to tubes for counting in a Beckman Gamma 5500 counter. Nonspecific binding, determined as radioactivity bound in the presence of 10 Ϫ 6 M unlabeled EGF, HB-EGF, or AR, was subtracted from total binding to obtain specific binding. All data points are expressed as mean Ϯ SEM of three separate experiments performed in triplicate.
Statistics and calculations. In the cell proliferation experiments, the significance of differences was evaluated by ANOVA followed by Duncan's multiple range test. Differences were considered significant if P Ͻ 0.05. Binding data were analyzed using the curve-fitting program EBDA/LIGAND (44).
Results
Effect of H. pylori on TGF ␣ , HB-EGF, and AR mRNA expression in MKN 28 cells.
Incubating MKN 28 cells with bacterial suspensions from the H. pylori 60190 (wild-type) strain for 4-48 h did not have any effect on TGF ␣ mRNA expression. There was, however, a time-dependent increase in HB-EGF and AR mRNA content in these cells in response to H. pylori (Fig. 1) . The increase in HB-EGF and AR mRNA expression was already evident after 4 and 12 h of treatment, respectively, reached a peak at 24 h (20-fold increase vs. control), and declined at 48 h (Fig. 1 ). To determine whether the increase in HB-EGF and AR mRNA expression was specific for H. pylori 60190, we evaluated the effect of a bacterial suspension from wild-type H. pylori strain CCUG 17874, and obtained comparable results (data not shown). Similar effects were obtained with bacterial suspensions and with broth culture filtrates from H. pylori 60190 or CCUG strains (data not shown). Therefore, in the subsequent experiments, we used H. pylori broth culture filtrates only.
Role of H. pylori virulence factors in upregulation of HB-EGF and AR mRNA expression. To identify potential H. pylori virulence factors responsible for HB-EGF induction and AR mRNA expression, MKN 28 cells were incubated for 24 h with uninoculated broth filtrate (control) or with broth culture filtrates from H. pylori 60190 (wild-type) strain, or its isogenic mutants lacking vacA, cagA, vacA, and cagA, picA, or picB . Fig. 2 A shows that a comparable increase in HB-EGF and AR mRNA expression was observed for all of the H. pylori strains tested. We also investigated whether urease-dependent ammonia generation might play a role in upregulating EGF-related peptides. Broth culture filtrates from a urease-positive (Bx2U ϩ ) strain and its urease-negative mutant (Bx2U Ϫ ) did not differ in their ability to induce HB-EGF or AR mRNA expression, nor did NH 4 Cl (4 mM) exert any effect on mRNA expression of either growth factor (Fig. 2 B ) . This concentration of NH 4 Cl was similar to the ammonia concentration present when MKN 28 cells were incubated with broth culture filtrates from all the urease-positive H. pylori strains used (15) . To determine whether similar effects were induced by other Gram-negative bacteria, we studied the effect of E. coli on the expression of growth factors. That incubation of cells with broth culture filtrate or cell suspension from a clinical E. coli isolate (ATCC 25922) did not have any effect on HB-EGF or AR mRNA expression compared with control ( Fig. 2 B and data not shown) suggests that the observed effects were due to unique properties of H. pylori . We have previously shown that the vacuolating cytotoxin and a yet unidentified low ( Ͻ 12 kD) molecular mass component inhibit proliferation of gastric mucosal cells (15) . To evaluate whether this low molecular mass bacterial product might be responsible for upregulating EGFr ligand mRNA expression, we incubated MKN 28 cells with dialyzed (to eliminate products Ͻ 12 kD) or undialyzed broth culture filtrates from wild-type strain 60190, or from its isogenic vacA Ϫ mutant. HB-EGF and AR mRNA expression was increased to 6 cells were incubated with DMEM (control) or with a bacterial suspension (5 ϫ 10 7 CFU/ml) from H. pylori 60190 (wild-type) for up to 48 h. Total RNA was isolated, Northern blots were performed using 10 g of total RNA per lane, and filters were sequentially hybridized to 32 P-labeled cDNA probes for human TGF␣, HB-EGF, AR, or GAPDH, as previously described (36) . The constitutively expressed GAPDH transcript was used to evaluate equivalence of RNA loading and transfer. A representative autoradiograph of four separate experiments is shown. C, control; Hp, H. pylori 60190.
a similar extent by dialyzed or undialyzed broth culture filtrates irrespective of expression of the vacuolating cytotoxin (Fig. 3) , suggesting that a high ( Ͼ 12 kD) molecular mass component other than VacA is responsible for this effect.
Effect of H. pylori on HB-EGF and AR protein release in the conditioned medium of MKN 28 cells.
To determine whether HB-EGF and AR protein production correlated with mRNA expression, conditioned medium from H. pylori-treated or -untreated (control) cells was analyzed by Western blot using antisera specific for HB-EGF and AR, respectively (Fig. 4 ). An HB-EGF immunoreactive peptide of ‫ف‬ 30 kD (Fig. 4 A) and an AR immunoreactive peptide of ‫ف‬ 10 kD (Fig. 4 B) were secreted in the conditioned medium from MKN 28 cells after 24 h of incubation with H. pylori 60190 broth culture filtrate, but were not detected in conditioned medium from MKN 28 cells treated with uninoculated broth filtrates. No HB-EGF or AR immunoreactive peptides were detected in H. pylori 60190 broth culture filtrate alone (data not shown). As expected, anti-human HB-EGF antibody and anti-human AR antibody also recognized recombinant human HB-EGF and AR peptides of 10 and 11 kD, respectively (Fig. 4) . The differences in molecular mass between rhHB-EGF and the rhAR and HB-EGF and AR secreted by MKN 28 cells might be due to differential processing of the prepropeptides in MKN 28 cells. In fact, it has been demonstrated that human keratinocytes secrete different molecular mass forms of HB-EGF ranging from 14.5 to 30 kD (45) . Similarly, low (9.5 kD) and high (16.5 kD) molecular mass forms of AR have been described in human breast carcinoma cells (46) . We previously have shown that H. pylori broth culture filtrates cause a significant decrease in the proliferative activity of MKN 28 cells (15) . This finding seemed to contradict our current data, which show that H. pylori induces HB-EGF and AR expression in MKN 28 cells, and that these cells proliferate in response to these two factors. Therefore, we studied whether H. pylori broth culture filtrates interfered with HB-EGF-or AR-induced proliferation of MKN 28 cells. We confirmed that broth culture filtrates from H. pylori wild-type strain 60190 or its isogenic vacA Ϫ mutant nearly abolished the proliferative activity of cultured cells, and now found ( (Fig. 6 B) . In contrast, pretreatment with H. pylori broth culture filtrates abrogated growth factor-induced mitogenesis (Fig. 6 B) . We also evaluated whether dialyzed broth culture filtrates from cytotoxic (wild-type) or noncytotoxic (VacA Ϫ ) H. pylori strains retained their ability to counteract EGF ligand-induced cell proliferation. We confirmed that dialyzed broth culture filtrate from the H. pylori wild-type strain retained its antiproliferative effect, and showed that this effect was not counteracted by coadministration of rhHB-EGF (10 nM) or rhAR (10 nM; Fig. 7 ). On the other hand, dialyzed broth culture filtrate from the isogenic vacA Ϫ mutant lost its ability to inhibit basal as well as EGF-related peptide-stimulated cell growth (Fig. 7) . These observations confirm that the vacuolating cytotoxin and a low (Ͻ 12 kD) molecular mass component play a role in inhibiting gastric cell proliferation, and suggest that both factors are important in counteracting EGF-related peptide-induced cell growth stimulation.
Effect of H. pylori broth culture filtrates on HB-EGF-or AR-induced MKN
Effect of H. pylori broth culture filtrate on EGF binding affinity and on number of specific binding sites for EGF.
Since the proliferative effects of HB-EGF and AR are mediated through the EGFr (16, 27), we hypothesized that H. pyloriinduced inhibition of EGF-related peptide-dependent cell growth might be mediated by EGFr downregulation. To address this issue, we performed experiments designed to quan- Figure 4 . Effect of H. pylori broth culture filtrates on HB-EGF and AR protein levels in the conditioned medium of MKN 28 cells. Approximately 2 ϫ 10 6 cells were incubated for 24 h with uninoculated broth filtrate (control) or broth culture filtrate from H. pylori 60190 strain (wild-type; each diluted 1:3 in serum-free medium). 50 l of concentrated conditioned medium was electrophoresed through 12% (A) or 15% (B) SDS-PAGE under nonreducing conditions and blotted to nitrocellulose filters. Immunodetection was performed using antihuman HB-EGF (A) or anti-human AR (B) antibody. The amount of samples loaded was standardized according to protein concentration. 10 ng of rhHB-EGF or rhAR was loaded in the third lanes as controls. Migration of molecular weight markers is indicated on the left of each panel. (Fig. 8 A) . When the specific binding was evaluated by Scatchard plot analysis, a single class of high-affinity binding sites for EGF, HB-EGF, and AR was identified (Fig. 8 B and data (Fig. 9 A, top) . Also, the EGFr total protein levels were similar in cells treated with supernatants from H. pylori cultures or from uninoculated broth filtrate (Fig. 9 A, bottom) . Immunoprecipitation of protein extracts with an anti-EGFr antibody followed by Western blot analysis with an antiphosphotyrosine antibody showed that control (untreated) cells had undetectable levels of tyrosine-phosphorylated EGFr, whereas H. pylori treatment caused detectable tyrosine phosphorylation of the EGFr (Fig. 9 B) . Also, H. pylori treatment did not alter HB-EGF-or AR-dependent EGFr tyrosine phosphorylation (Fig. 9 B) . In particular, densitometric analysis of the experiment shown in Fig. 9 B demonstrated that the antiphosphotyrosine/anti-EGFr ratio was close to 0 in control untreated cells, 0.6 in H. pyloritreated cells, and 3 and 2.5 vs. 4 and 3.5 after administration of rhHB-EGF (10 nM) or rhAR (10 nM) to control untreated cells and H. pylori-treated cells, respectively. Thus, there was no evidence that H. pylori filtrate inhibited activation of the EGFr.
Discussion
H. pylori infection is associated with development of gastroduodenal mucosal ulceration (1, 2), and with an increased risk of gastric adenocarcinoma in humans (3, 4) . Host response and environmental factors are important in the pathogenesis of H. pylori-related gastroduodenal disease (5, 6). However, molecules expressed by ‫ف‬ 60% of wild-type isolates of H. pylori have been identified that may participate in the pathogenesis of H. pylori-induced disease (7-11). In particular, H. pylori strains preferentially associated with development of peptic ulcer or gastric adenocarcinoma express vacuolating cytotoxin activity (i.e., Tox ϩ ; 7-9) and an immunodominant antigen associated with the cytotoxin (i.e., CagA; references 10 and 11). Multiple genes in the cag island have recently been described, whose expression are necessary for cytokine production by gastric epithelial cells in vitro (33, 47) .
EGF-related peptides have been shown to prevent druginduced damage to the stomach, and to accelerate healing of gastric mucosal ulcerations (17, 18) , suggesting that EGF ligands play a major role in maintaining gastric mucosal integrity (26, 27, 48, 49) . In particular, HB-EGF recently has been demonstrated to be expressed in the normal human gastric mucosa (50) , and to be upregulated after acute injury to the rat stomach (51) or kidney (52). Therefore, we studied whether H. pylori might affect EGF-related peptide expression in gastric mucosal cells in vitro. Our data show that H. pylori upregulates expression of AR and HB-EGF at the mRNA and protein levels, effects not only observed with H. pylori suspensions, but also with broth culture filtrates, suggesting that it might be mediated by a soluble product released from the bacterium. Our data indicate that the H. pylori factor involved in upregulation of EGF-related peptide expression is Ͼ 12 kD, and that none of several known virulence factors, including vacA, cagA, picA, or picB, mediates this effect. Moreover, urease-generated ammonia does not seem to play a role in this effect since NH 4 Cl did not increase AR or HB-EGF mRNA expression, and a urease-negative H. pylori strain was as effective as its isogenic wild-type (urease positive) strain in upregulating AR and HB-EGF mRNA transcripts. The possibility that overexpression of AR and HB-EGF is a non specific phenomenon due to a component common to all Gram-negative bacteria is ruled out by the finding that E. coli did not affect AR or HB-EGF mRNA levels. We also found that H. pylori treatment induced release of HB-EGF and AR protein in the conditioned media of cultured cells. An HB-EGF immunoreactive peptide of 30 kD and an AR immunoreactive peptide of 10 kD were identified. These different molecular weight forms of HB-EGF and AR have been found to be biologically active (45, 46) . Secretion of HB-EGF and AR in the conditioned medium together with the finding that either peptide dose-dependently stimulated gastric cell proliferation as assessed by [ 3 H]thymidine incorporation suggests that these peptides may play an autocrine role in MKN 28 cell proliferation. Recent epidemiological studies indicate that H. pylori is involved in the development of adenocarcinoma of the distal stomach (3, 4) . The pathogenetic mechanisms are not known, but increased proliferative activity of epithelial cells in gastric mucosa colonized by H. pylori might contribute (53, 54). Since increased expression of HB-EGF and AR has been described in gastrointestinal malignancies in humans (55, 56) , we speculate that sustained overexpression of EGF-related peptides in persons colonized with H. pylori might overcome the acute inhibitory effect on cell growth exerted by H. pylori (15) , thus leading to increased proliferation of gastric mucosal cells and, in turn, to development of gastric cancer. However, in vivo studies in H. pylori-colonized gastric mucosa are needed to verify this hypothesis.
We have previously shown in the same experimental model that H. pylori broth culture filtrates inhibited gastric mucosal cell proliferation (15) . That H. pylori broth culture filtrates given either as a pretreatment or together with growth factors, completely abolished the growth stimulatory effect of AR or HB-EGF, suggests that increased production of these peptides after acute exposure to H. pylori is insufficient to counteract the marked inhibitory effect on cell growth exerted by H. pylori. We previously described that after dialysis with a 12-kD cutoff, broth culture filtrate from H. pylori wild-type strain 60190 retained its ability to inhibit cell proliferation, whereas broth culture filtrate from its isogenic noncytotoxic strain did not. Moreover, inhibition of cell proliferation induced by dialyzed broth culture filtrate from the cytotoxic H. pylori strain was specifically counteracted by pretreatment with a neutralizing polyclonal antiserum raised against purified VacA (15). These observations suggest that H. pylori-induced inhibition of cell proliferation is due in part to the vacuolating cytotoxin, and in part to a low (Ͻ 12 kD) molecular mass component. Herein we have shown that after dialysis, the H. pylori wildtype strain retained its ability to counteract HB-EGF-or ARinduced cell growth, whereas the H. pylori noncytotoxic strain did not. This observation, together with the demonstration that neither the vacuolating cytotoxin nor a low molecular mass bacterial product are involved in upregulating HB-EGF or AR mRNA expression (Fig. 3) , suggests that separate factors are involved in inducing EGF-related peptide expression, and in inhibiting their proliferative activity. In particular, upregulation of HB-EGF and AR expression appears to be due to a high (Ͼ 12 kD) molecular mass component other than the vacuolating cytotoxin, since this effect is observed with both cytotoxic and noncytotoxic strains after dialysis. On the contrary, inhibition of basal as well as EGFr ligand-stimulated cell growth depends on the vacuolating cytotoxin, and is also contributed to by a low (Ͻ 12 kD) molecular mass bacterial product. That the cytotoxic strain retains its antiproliferative activity after dialysis, whereas the noncytotoxic strain does not, suggests that these separate factors might ultimately be the targets of different therapeutic interventions.
The biological effects of EGF-related peptides are mediated through interaction with a common cell membrane receptor (i.e., the EGFr; references 16 and 27). EGFr expression is upregulated after injury to the mucosa of the gastrointestinal tract (25) . Inhibition of the tyrosine kinase specific for the EGFr impairs the protective effect of EGF against experimentally induced colitis in the rat (57). We found that either HB-EGF or AR competed at high affinity for [ Another mechanism of H. pylori-induced inhibition of growth factor-stimulated cell growth might be through inhibition of HB-EGF or AR-dependent activation of the EGFr (60). We therefore studied the effect of H. pylori on tyrosine phosphorylation of the EGFr induced by exogenous administration of HB-EGF or AR. Because of the comparable levels of either HB-EGF or AR-dependent tyrosine phosphorylation of the EGFr observed in monolayers treated with H. pylori broth culture filtrates and in control (untreated) monolayers, we speculate that H. pylori may act by altering the EGFr signal transduction pathway downstream to the activation of the receptor directly, or through activation of other signal transduction pathways, such as the JNK/SAPK signalling pathway, that leads to inhibition of cell growth (61) . Studies are underway in our laboratory to address this issue.
In conclusion, our study suggests that exposure of gastric mucosal cells to H. pylori leads to increased production of EGF-related growth factors. Induction of these growth factors is not sufficient to counteract the growth inhibitory effect exerted by H. pylori, at least in this acute experimental setting. Inhibition of EGF-related peptide-dependent cell growth does not seem to be due to downregulation of the EGFr, or to inhibition of EGFr activation. Finally, upregulation of EGF-related growth factors and inhibition of their stimulatory effect on cell growth appear to be mediated by separate H. pylori factors. We speculate that inhibition of reparative events mediated by EGF-related peptides might play a role in the pathogenesis of H. pylori-induced acute damage to the gastroduodenal mucosa in vivo.
